Work

Risk of Secondary Malignancy in CLL Patients Treated with Novel Targeted Agents

Year: 2020

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2020-140042

Authors: Anna Eversman, Shufen Cao, Kirsten M Boughan, Molly M Gallogly, Ehsan Malek, Leland Metheny, Timothy E. O'Brien, Folashade Otegbeye, Brenda W. Cooper, Pingfu Fu, Marcos de Lima, Paolo F Caimi

Institutions: Case Western Reserve University, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096123598

FWCI: 0.259

Cites:

Cited by: 5

Related to: 10